Company Monitoring Page for Vivus

latest headlines for company on cafepharma

5 High-Impact Biotech Catalysts to Watch This Week
Seeking Alpha
Tue, 10/26/10 - 11:19 am
Tags:
Arena Pharmaceuticals, Avanir, Biodel, EXACT Sciences, Vivus
VIVUS Shares Plunged: What You Need to Know
Motley Fool
Wed, 10/20/10 - 01:54 pm
Tags:
Vivus, Qnexa
Vivus Sells MUSE to Meda
Yahoo/Zacks
Sun, 10/17/10 - 11:11 am
Tags:
Vivus, Meda, Muse, erectile dysfunction
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thu, 10/14/10 - 09:29 am
Tags:
FDA, Hospira, Human Genome Sciences, Alexza, Jazz Pharmaceuticals, Alkermes, Arena Pharmaceuticals, Amylin, Vivus, Avanir, Forest Labs, Biodel
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Tags:
Linjeta, Biodel, Afrezza, MannKind, FDA, Benlysta, Human Genome, GSK, Bydureon, Eli Lilly, Amylin, Alkermes, Brilinta, AstraZeneca, Pradaxa, Boehringer Ingelheim, Qnexa, Vivus, Contrave, Orexigen, ipilimumab, Bristol-Myers Squibb, Merck KGaA, cladribine
Orexigen Shares Popped: What You Need to Know
Motley Fool
Thu, 10/7/10 - 06:04 pm
Tags:
Orexigen, obesity, Arena Pharmaceuticals, Vivus
Why The FDA Keeps Rejecting Obesity Pills
Forbes
Mon, 10/4/10 - 05:19 pm
Tags:
FDA, obesity, Arena Pharmaceuticals, Lorqess, Vivus, Qnexa
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Mon, 09/27/10 - 10:43 am
Tags:
obesity, Vivus, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
Seeking Alpha
Sun, 09/26/10 - 12:22 pm
Tags:
Qnexa, Vivus, obesity
Vivus Rallies on Positive Results for Obesity Drug
Seeking Alpha
Wed, 09/22/10 - 10:06 am
Tags:
Vivus, obesity, Qnexa
Vivus: Weight Loss Extends Two Years
TheStreet.com
Tue, 09/21/10 - 12:07 pm
Tags:
obesity, Vivus, Qnexa
Biotech Investor Calendar: Obesity Drugs
TheStreet.com
Mon, 09/20/10 - 12:18 pm
Tags:
Vivus, Qnexa, Orexigen, obesity, Contrave, Arena Pharmaceuticals
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Sat, 09/18/10 - 11:07 am
Tags:
Ista, Alexza, Biodel, Alkermes, Vivus
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Tags:
Arena Pharmaceuticals, obesity, Takeda, Orexigen, Contrave, Abbott Laboratories, Meridia, Qnexa, Vivus
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Qnexa, Contrave, Orexigen
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
Seeking Alpha
Mon, 09/6/10 - 10:04 am
Tags:
Arena Pharmaceuticals, obesity, lorcaserin, Qnexa, Meridia, Vivus
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Fri, 09/3/10 - 11:57 am
Tags:
Arena Pharmaceuticals, Contrave, Orexigen, Vivus, obesity, Qnexa
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
Tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Vivus' Qnexa Panel Bodes Well for Arena's Obesity Drug
Seeking Alpha
Mon, 08/30/10 - 10:44 am
Tags:
Qnexa, Vivus, advisory panels, Arena Pharmaceuticals, obesity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.